Uk-listed @avacta #AVCT. Targeted oncology.
It owns the pre|CISON platform, which has a unique method of delivering highly toxic anti-cancer medicines to solid tumours, dramatically reducing unwanted side-effects whilst simultaneously dramatically boosting drug efficacy.
In the uber bull case scenario, Avacta’s Pre|CISION peptide-drug conjugates could almost entirely displace the antibody-drug conjugate market - which Morgan Stanley predicts will be a $140bn market in 10 years’ time.
I believe that will be a fight for Avacta by numerous Big Pharma names next year.
#AVCT was one of the top 10 most-traded stocks on the interactive investor platform during the morning trading session of 6 October 2025.
69% of trades were deemed buys.